The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Open accessAbstract
OBJECTIVES: There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy. METHODS: The ESCEO expert working group met to discuss the epidemiological and economic evidence that justifies the increasing concern of the impact of this disease and reviewed the current state-of-the-art in health economic studies in this field. RESULTS: OA is a debilitating disease; it is increasing in frequency and is associated with a substantial and growing burden on society, in terms of both burden of illness and cost of illness. Economic evaluations in this field are relatively rare, and those that do exist, show considerable heterogeneity of methodological approach (such as indicated population, comparator, decision context and perspective, time horizon, modeling and outcome measures used). This heterogeneity makes comparisons between studies problematic. CONCLUSIONS: Better adherence to guidelines for economic evaluations is needed. There was strong support for the definition of a reference case and for what might constitute "standard optimal care" in terms of best clinical practice, for the control arms of interventional studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationGRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Self-citationHochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Self-citationZhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796 · cited 8×
“Acupuncture added by OARSI & ACR Therapeutic options in OA grouped according to weight of evidence and the rela E, 2008). tive Cost–utility analysis: where therapies are compared on their costs and outcomes, based on their utility (the quality of living adjusted by a value given by society) QALYs.”
InfluentialSelf-citationAltman, R., Alarcón, G., Appelrouth, D., Bloch, D., Borenstein, D., Brandt, K., Brown, C., Cooke, T. D., Daniel, W., Feldman, D., et al. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340502 · Cited by 2,632
Self-citationQuality of life and pharmacoeconomics in clinical trials
Pater, J. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)82191-5 · Cited by 2,395
Osteoarthritis: an update with relevance for clinical practice
Bijlsma, J. W., Berenbaum, F., & Lafeber, F. P. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60243-2 · Cited by 2,288
Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group
van Tulder, M., Furlan, A., Bombardier, C., & Bouter, L. (2003) · Spine · doi:10.1097/01.brs.0000065484.95996.af · Cited by 2,180
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048
Self-citationQuality of life and pharmacoeconomics in clinical trials
Spilker, B. (1996) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,862
Macroeconomics and health: investing in health for economic development
Sachs, J. D. (2002) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892002000800017 · Cited by 1,830
Ethgen, O., Bruyère, O., Richy, F., Dardennes, C., & Reginster, J.-Y. (2004) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-200405000-00012 · Cited by 1,800
Self-citationConsolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
Kurtz, S. M., Lau, E., Ong, K., Zhao, K., Kelly, M., & Bozic, K. J. (2009) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-009-0834-6 · Cited by 1,502
Zhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Self-citationCarr, A. J., Robertsson, O., Graves, S., Price, A. J., Arden, N. K., Judge, A., & Beard, D. J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60752-6 · Cited by 1,149
Self-citationAltman, R., Alarcon, G., Appelrouth, D., Bloch, D., Borenstein, D., Brandt, K., Brown, C., Cooke, T. D., Daniel, W., Gray, R., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331101 · Cited by 1,132
Self-citationARDEN, N., & NEVITT, M. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.09.007 · Cited by 1,130
Self-citationThe effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review
Pereira, D., Peleteiro, B., Araújo, J., Branco, J., Santos, R. A., & Ramos, E. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.08.009 · Cited by 843
Self-citationEichler, H.-G., Kong, S. X., Gerth, W. C., Mavros, P., & Jönsson, B. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.75003.x · Cited by 788
Zhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Gunther, K.-P., Hauselmann, H. J., Herrero-Beaumont, G., Jordan, K., Kaklamanis, P., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.028886 · Cited by 785
Self-citationBellamy, N., Kirwan, J., Boers, M., Brooks, P., Strand, V., Tugwell, P., Altman, R. D., Brandt, K. D., Dougados, M., & Lequesne, M. G. (1997) · PubMed · Cited by 745
Self-citationNuesch, E., Dieppe, P., Reichenbach, S., Williams, S., Iff, S., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.d1165 · Cited by 730
Ramsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., Cook, J., Glick, H., Liljas, B., Petitti, D., et al. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.00045.x · Cited by 720
Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life
Buxton, M. J., Drummond, M. F., Van Hout, B. A., Prince, R. L., Sheldon, T. A., Szucs, T., & Vray, M. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199705)6:3<217::aid-hec267>3.0.co;2-w · Cited by 595
Cost-effectiveness of Total Knee Arthroplasty in the United States: Patient Risk and Hospital Volume
Losina, E., Walensky, R. P., Kessler, C. L., Emrani, P. S., Reichmann, W. M., Wright, E. A., Holt, H. L., Solomon, D. H., Yelin, E., Paltiel, A. D., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.136 · Cited by 560
Ström, O., Borgström, F., Kanis, J. A., Compston, J., Cooper, C., McCloskey, E. V., & Jönsson, B. (2011) · Archives of Osteoporosis · doi:10.1007/s11657-011-0060-1 · Cited by 546
Self-citationWhither trial‐based economic evaluation for health care decision making?
Sculpher, M. J., Claxton, K., Drummond, M., & McCabe, C. (2006) · Health Economics · doi:10.1002/hec.1093 · Cited by 407
Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES
Ofman, J. J., Sullivan, S. D., Neumann, P. J., Chiou, C.-F., Henning, J. M., Wade, S. W., & Hay, J. W. (2003) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2003.9.1.53 · Cited by 366
The need to address the burden of musculoskeletal conditions
Woolf, A. D., Erwin, J., & March, L. (2012) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2012.03.005 · Cited by 357
Chen, Y., Jobanputra, P., Barton, P., Bryan, S., Fry-Smith, A., Harris, G., & Taylor, R. (2008) · Health Technology Assessment · doi:10.3310/hta12110 · Cited by 339
The cost-effectiveness of total joint arthroplasty: A systematic review of published literature
Daigle, M. E., Weinstein, A. M., Katz, J. N., & Losina, E. (2012) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2012.07.013 · Cited by 333
Predicting the cost-effectiveness of total hip and knee replacement: A health economic analysis
Jenkins, P. J., Clement, N. D., Hamilton, D. F., Gaston, P., Patton, J. T., & Howie, C. R. (2013) · The Bone & Joint Journal · doi:10.1302/0301-620x.95b1.29835 · Cited by 326
10 Economics of osteoarthritis: a global perspective
March, L. M., & Bachmeier, C. J. M. (1997) · Baillière's Clinical Rheumatology · doi:10.1016/s0950-3579(97)80011-8 · Cited by 317
Black, C., Clar, C., Henderson, R., MacEachern, C., McNamee, P., Quayyum, Z., Royle, P., & Thomas, S. (2009) · Health Technology Assessment · doi:10.3310/hta13520 · Cited by 291
OECD (2011) · Health at a glance · doi:10.1787/health_glance-2011-en · Cited by 289
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
Brunetti, M., Shemilt, I., Pregno, S., Vale, L., Oxman, A. D., Lord, J., Sisk, J., Ruiz, F., Hill, S., Guyatt, G. H., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.04.012 · Cited by 286
The increasing impact of arthritis on public health.
Elders, M. J. (2000) · PubMed · Cited by 283
The Impact of Osteoarthritis in the United States: A Population-Health Perspective
Murphy, L., & Helmick, C. G. (2012) · AJN, American Journal of Nursing · doi:10.1097/01.naj.0000412646.80054.21 · Cited by 252
Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans
Losina, E., Walensky, R. P., Reichmann, W. M., Holt, H. L., Gerlovin, H., Solomon, D. H., Jordan, J. M., Hunter, D. J., Suter, L. G., Weinstein, A. M., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00001 · Cited by 244
Self-citationObjective physical activity measurement in the osteoarthritis initiative: Are guidelines being met?
Dunlop, D. D., Song, J., Semanik, P. A., Chang, R. W., Sharma, L., Bathon, J. M., Eaton, C. B., Hochberg, M. C., Jackson, R. D., Kwoh, C. K., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30562 · Cited by 240
Self-citationThe Global Economic Cost of Osteoarthritis: How the UK Compares
Chen, A., Gupte, C., Akhtar, K., Smith, P., & Cobb, J. (2012) · Arthritis · doi:10.1155/2012/698709 · Cited by 220
Direct medical costs unique to people with arthritis.
Gabriel, S. E., Crowson, C. S., Campion, M. E., & O’Fallon, W. M. (1997) · PubMed · Cited by 200
Cochrane, T., Davey, R., & Matthes Edwards, S. (2005) · Health Technology Assessment · doi:10.3310/hta9310 · Cited by 195
Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle
Taylor, R. S., Drummond, M. F., Salkeld, G., & Sullivan, S. D. (2004) · BMJ · doi:10.1136/bmj.329.7472.972 · Cited by 194
Berger, M. L., Dreyer, N., Anderson, F., Towse, A., Sedrakyan, A., & Normand, S.-L. (2012) · Value in Health · doi:10.1016/j.jval.2011.12.010 · Cited by 189
Dougados, M., Leclaire, P., van der Heijde, D., Bloch, D. A., Bellamy, N., & Altman, R. D. (2000) · Osteoarthritis and Cartilage · doi:10.1053/joca.2000.0361 · Cited by 186
Dunlop, D. D., Song, J., Semanik, P. A., Sharma, L., & Chang, R. W. (2011) · Arthritis & Rheumatism · doi:10.1002/art.27760 · Cited by 173
Modelling in Health Economic Evaluation: What is its Place? What is its Value?
Brennan, A., & Akehurst, R. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017050-00004 · Cited by 164
Is there a kink in consumers' threshold value for cost‐effectiveness in health care?
OʼBrien, B. J., Герцен, К. А., Willan, A. R., & Faulkner, A. (2002) · Health Economics · doi:10.1002/hec.655 · Cited by 155
Productivity costs and medical costs among working patients with knee osteoarthritis
Hermans, J., Koopmanschap, M. A., Bierma‐Zeinstra, S., van Linge, J. H., Verhaar, J. A. N., Reijman, M., & Alex Burdorf, A. (2012) · Arthritis Care & Research · doi:10.1002/acr.21617 · Cited by 151
Total joint replacement in osteoarthritis
KATZ, J. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.09.003 · Cited by 136
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions
Cleemput, I., Neyt, M., Thiry, N., Laet, C. E. D. H. D., & Leys, M. (2011) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462310001194 · Cited by 129
Essentials of Pharmacoeconomics
Rascati, K. L. (2013) · Cited by 118
Maetzel, A., Krahn, M. D., & Naglie, G. (2003) · Arthritis Care & Research · doi:10.1002/art.11121 · Cited by 114
Emerging drugs for osteoarthritis
Matthews, G., & Hunter, D. J. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.576670 · Cited by 114
Self-citationLatimer, N. R., Lord, J. L., Grant, R. L., O’Mahony, R., Dickson, J., & Conaghan, P. G. (2009) · BMJ · doi:10.1136/bmj.b2538 · Cited by 113
Loew, L., Brosseau, L., Wells, G. A., Tugwell, P., Kenny, G. P., Reid, R. D., Maetzel, A., Huijbregts, M. P. J., McCullough, C., Angelis, G. D., et al. (2012) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2012.01.024 · Cited by 112
Self-citationHochberg, M. C. (2008) · PubMed · Cited by 110
Self-citationDiBonaventura, M., Gupta, S., McDonald, M., Sadosky, A., Pettitt, D., & Silverman, S. L. (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-30 · Cited by 106
Self-citationBrosseau, L., Wells, G. A., Tugwell, P., Egan, M. Y., Dubouloz, C., Casimiro, L., Bugnariu, N., Welch, V. A., Angelis, G. D., Francoeur, L., et al. (2011) · Physical Therapy · doi:10.2522/ptj.20100104 · Cited by 106
Self-citationPinto, D., Robertson, M. C., Hansen, P., & Abbott, J. H. (2012) · Value in Health · doi:10.1016/j.jval.2011.09.003 · Cited by 105
Self-citationDong, H., & Buxton, M. J. (2006) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462306051014 · Cited by 105
Bruyère, O., Ethgen, O., Neuprez, A., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J. (2012) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-012-1583-7 · Cited by 104
Self-citationJessep, S., Walsh, N. E., Ratcliffe, J., & Hurley, M. (2009) · Physiotherapy · doi:10.1016/j.physio.2009.01.005 · Cited by 103
Gossec, L., HAWKER, G. A., Davis, A. M., Maillefert, J. F., Lohmander, S. L., Altman, R. D., Cibere, J., Conaghan, P. G., Hochberg, M. C., Jordan, J. M., et al. (2007) · PubMed · Cited by 101
Self-citationHurley, M. V., Walsh, N. E., Mitchell, H., Pimm, J., Williamson, E., Jones, R. H., Reeves, B. C., Dieppe, P. A., & Patel, A. K. (2007) · Arthritis Care & Research · doi:10.1002/art.23011 · Cited by 98
Cottrell, E., Roddy, E., & Foster, N. E. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-4 · Cited by 90 · cited 1×
“In part, this is because the percentage of GPs who actually advise their OA patients to exercise or refer them for physical therapy can be very low, with rates varying between 6% and 63% [65].”
BackgroundQuality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain
Reinhold, T., Witt, C. M., Jena, S., Brinkhaus, B., & Willich, S. N. (2007) · The European Journal of Health Economics · doi:10.1007/s10198-007-0062-5 · Cited by 87
Lord, J. L., Victor, C. R., Littlejohns, Ross, & Axford (1999) · Health Technology Assessment · doi:10.3310/hta3230 · Cited by 85
Changing life-styles and osteoarthritis: what is the evidence?
Roddy, E., & Doherty, M. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.09.006 · Cited by 78
Introducing GRADE across the NICE clinical guideline program
Thornton, J., Alderson, P., Tan, T., Turner, C., Latchem, S., Shaw, E. J., Ruiz, F. J., Reken, S., Mugglestone, M. A., Hill, J., et al. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.12.007 · Cited by 69
The excess burden of osteoarthritis in the province of Ontario, Canada
Tarride, J., Haq, M., O’Reilly, D. J., Bowen, J. M., Xie, F., Dolovich, L. R., & Goeree, R. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33467 · Cited by 66
Bellamy, N., Bell, M. J., Goldsmith, C. H., Pericak, D., Walker, V., Raynauld, J., Torrance, G. W., Tugwell, P., & Polisson, R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.026443 · Cited by 65
Self-citationKamath, C. C., Kremers, H. M., Vanness, D. J., O’Fallon, W. M., Cabanela, R. L., & Gabriel, S. E. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.00215.x · Cited by 64
Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain.
Mapel, D. W., Shainline, M. R., Paez, K., & Gunter, M. (2004) · PubMed · Cited by 63
Cost-Effectiveness Acceptability Curves and a Reluctance to Lose
Severens, J. L., Brunenberg, D., Fenwick, E. A. L., Brien, B. O., & Joore, M. A. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523120-00005 · Cited by 61
Self-citationCoupé, V. M. H., Veenhof, C., van Tulder, M. W., Dekker, J., Bijlsma, J. W. J., & van den Ende, C. H. M. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054478 · Cited by 59
New treatments for osteoarthritis
Smelter, E., & Hochberg, M. C. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835f69b4 · Cited by 58
Self-citationEconomic evaluation of arthritis self management in primary care
Patel, A. K., Buszewicz, M., Beecham, J. K., Griffin, M., Rait, G., Nazareth, I., Atkinson, A., Barlow, J., & Haines, A. (2009) · BMJ · doi:10.1136/bmj.b3532 · Cited by 55
Manning, V., Hurley, M., Scott, D. L., & Bearne, L. (2012) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e3182779cb6 · Cited by 53
Song, J., Hochberg, M. C., Chang, R. W., Hootman, J. M., Manheim, L. M., Lee, J. J., Semanik, P. A., Sharma, L., Dunlop, D. D., & for the Osteoarthritis Initiative Investigators (2012) · Arthritis Care & Research · doi:10.1002/acr.21803 · Cited by 52
Self-citationCommentary: Europe needs a central, transparent, and evidence based regulation process for devices
Eikermann, M., Gluud, C. N., Perleth, M., Wild, C., Sauerland, S., Gutiérrez‐Ibarluzea, I., Antoine, S., Demotes‐Mainard, J., Neugebauer, E. A. M., & Union*, O. B. O. S. O. O. O. L. T. T. E. (2013) · BMJ · doi:10.1136/bmj.f2771 · Cited by 50
Husereau, D., Drummond, M., Petrou, S. P., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Cited by 47
Rehabilitation and Total Joint Arthroplasty
Westby, M. D. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.05.005 · Cited by 42
Rehabilitation Following Total Knee Replacement, Total Hip Replacement, and Hip Fracture
Herbold, J., Bonistall, K., & Walsh, M. B. (2011) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0b013e318216db81 · Cited by 40
A Review of Health-Utility Data for Osteoarthritis: Implications for Clinical Trial-Based Evaluation
Ruchlin, H. S., & Insinga, R. P. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826110-00005 · Cited by 39
An economic model of long-term use of celecoxib in patients with osteoarthritis
Loyd, M., Rublee, D. A., & Jacobs, P. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-25 · Cited by 26
Contreras-Hernández, I., Mould-Quevedo, J. F., Torres-González, R., Goycochea-Robles, M. V., Pacheco-Domínguez, R. L., Sánchez‐García, S., Mejía‐Aranguré, J. M., & Garduño‐Espinosa, J. (2008) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-6-21 · Cited by 25
Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology
Gabriel, S. E., Tugwell, P., & Drummond, M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.4.370 · Cited by 25
Self-citationWard, A., Bozkaya, D., Fleischmann, J., Dubois, D., Sabatowski, R., & Caro, J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x219643 · Cited by 22
Valuing Health for Clinical and Economic Decisions: Directions Relevant for Rheumatologists
Harrison, M. J., Bansback, N. J., Marra, C. A., Drummond, M., Tugwell, P., & Boonen, A. E. R. C. H. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110404 · Cited by 20
Self-citationAl, M., Maniadakis, N., Grijseels, E. W. M., & Janssen, M. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00303.x · Cited by 19
Defining osteoarthritis: a moving target
Nelson, A. E., & Jordan, J. M. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.10.008 · Cited by 18
Cited by
Glyn-Jones, S., Palmer, A. J. R., Agricola, R., Price, A. J., Vincent, T. L., Weinans, H., & Carr, A. J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60802-3 · Cited by 3,151
Martel-Pelletier, J., Barr, A. J., Cicuttini, F. M., Conaghan, P. G., Cooper, C., Goldring, M. B., Goldring, S. R., Jones, G., Teichtahl, A. J., & Pelletier, J.-P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.72 · Cited by 1,877
Self-citationThe individual and socioeconomic impact of osteoarthritis
Hunter, D. J., Schofield, D., & Callander, E. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.44 · Cited by 1,238
Self-citationarcOGEN Consortium, Tachmazidou, I., Hatzikotoulas, K., Southam, L., Esparza-Gordillo, J., Haberland, V., Zheng, J., Johnson, T., Koprulu, M., Zengini, E., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0327-1 · Cited by 516
Bruyère, O., Cooper, C., Pelletier, J.-P., Branco, J., Luisa Brandi, M., Guillemin, F., Hochberg, M. C., Kanis, J. A., Kvien, T. K., Martel-Pelletier, J., et al. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.05.014 · Cited by 515
Self-citation
Metadata
- Authors
- Hiligsmann, M., Cooper, C., Arden, N., Boers, M., Branco, J. C., Luisa Brandi, M., Bruyère, O., Guillemin, F., Hochberg, M. C., Hunter, D. J., Kanis, J. A., Kvien, T. K., Laslop, A., Pelletier, J.-P., Pinto, D., Reiter-Niesert, S., Rizzoli, R., Rovati, L. C., Severens, J. L. (., Silverman, S., Tsouderos, Y., Tugwell, P., & Reginster, J.-Y.
- Venue
- Seminars in Arthritis and Rheumatism
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 43
- Issue
- 3
- Pages
- 303-313
- ISSN
- 0049-0172 (ISSN-L)
- OpenAlex
- W2166859708
- Cited by
- 327
- References
- 95
- FWCI
- 34.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.